Advertisement

The Patient with Severe Co-morbidities: CNS Disease and Increased Intracranial Pressure

  • Prashanth Nandhabalan
  • Chris Willars
  • Georg Auzinger
Chapter

Introduction

Intracranial hypertension presents specific challenges for the anesthesiologist during liver transplantation. The goal of reducing and avoiding surges of intracranial pressure is often in conflict with general anesthetic goals. It is crucial to maintain cerebral perfusion and protect the brain during surgery. Neurological complications are frequent and can be detrimental. This chapter will review the pathophysiology of intracranial hypertension in acute liver failure as well as perioperative strategies to prevent and treat it in order to avoid catastrophic neurological outcomes.

Intracranial Hypertension in Acute Liver Failure

Etiology and Pathophysiology of Encephalopathy and Cerebral Edema in Acute Liver Failure

Intracranial hypertension (ICH) is a common cause of death in acute liver failure (ALF) [1]. The concept of cerebral edema and hyperemia as a cause of the acute rise in intracranial pressure (ICP) in ALF was first described in the early 1970s [2]. While the...

Keywords

Intracranial hypertension Ammonia Cerebral blood flow Intracranial pressure Transcranial Doppler Therapeutic hypothermia Cerebral edema Hepatic encephalopathy 

References

  1. 1.
    O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97(2):439–45.CrossRefPubMedGoogle Scholar
  2. 2.
    Ware AJ, D’Agostino AN, Combes B. Cerebral edema: a major complication of massive hepatic necrosis. Gastroenterology. 1971;61(6):877–84.PubMedGoogle Scholar
  3. 3.
    Bernal W, Hyyrylainen A, Gera A, Audimoolam VK, McPhail MJ, Auzinger G, et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol. 2013;59(1):74–80.CrossRefPubMedGoogle Scholar
  4. 4.
    Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology. 2007;46(6):1844–52.CrossRefPubMedGoogle Scholar
  5. 5.
    Kumar R, Shalimar Sharma H, Prakash S, Panda SK, Khanal S, et al. Persistent hyperammonemia is associated with complications and poor outcomes in patients with acute liver failure. Clin Gastroenterol Hepatol. 2012;10(8):925–31.CrossRefPubMedGoogle Scholar
  6. 6.
    Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology. 1999;29(3):648–53.CrossRefPubMedGoogle Scholar
  7. 7.
    Rama Rao KV, Jayakumar AR, Norenberg MD. Brain edema in acute liver failure: mechanisms and concepts. Metab Brain Dis. 2014;29(4):927–36.CrossRefPubMedGoogle Scholar
  8. 8.
    Kato M, Hughes RD, Keays RT, Williams R. Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure. Hepatology. 1992;15(6):1060–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Swain M, Butterworth RF, Blei AT. Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver failure in rats. Hepatology. 1992;15(3):449–53.CrossRefPubMedGoogle Scholar
  10. 10.
    Record CO, Buxton B, Chase RA, Curzon G, Murray-Lyon IM, Williams R. Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Investig. 1976;6(5):387–94.CrossRefGoogle Scholar
  11. 11.
    Tofteng F, Hauerberg J, Hansen BA, Pedersen CB, Jorgensen L, Larsen FS. Persistent arterial hyperammonemia increases the concentration of glutamine and alanine in the brain and correlates with intracranial pressure in patients with fulminant hepatic failure. J Cereb Blood Flow Metab. 2006;26(1):21–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Albrecht J, Norenberg MD. Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology. 2006;44(4):788–94.CrossRefPubMedGoogle Scholar
  13. 13.
    Desjardins P, Du T, Jiang W, Peng L, Butterworth RF. Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure: role of glutamine redefined. Neurochem Int. 2012;60(7):690–6.CrossRefPubMedGoogle Scholar
  14. 14.
    Ranjan P, Mishra AM, Kale R, Saraswat VA, Gupta RK. Cytotoxic edema is responsible for raised intracranial pressure in fulminant hepatic failure: in vivo demonstration using diffusion-weighted MRI in human subjects. Metab Brain Dis. 2005;20(3):181–92.CrossRefPubMedGoogle Scholar
  15. 15.
    Rai V, Nath K, Saraswat VA, Purwar A, Rathore RK, Gupta RK. Measurement of cytotoxic and interstitial components of cerebral edema in acute hepatic failure by diffusion tensor imaging. J Magn Reson Imaging. 2008;28(2):334–41.CrossRefPubMedGoogle Scholar
  16. 16.
    Nguyen JH. Blood-brain barrier in acute liver failure. Neurochem Int. 2012;60(7):676–83.CrossRefPubMedGoogle Scholar
  17. 17.
    Cauli O, Lopez-Larrubia P, Rodrigo R, Agusti A, Boix J, Nieto-Charques L, et al. Brain region-selective mechanisms contribute to the progression of cerebral alterations in acute liver failure in rats. Gastroenterology. 2011;140(2):638–45.CrossRefPubMedGoogle Scholar
  18. 18.
    Coltart I, Tranah TH, Shawcross DL. Inflammation and hepatic encephalopathy. Arch Biochem Biophys. 2013;536(2):189–96.CrossRefPubMedGoogle Scholar
  19. 19.
    Jalan R, Olde Damink SWM, Hayes PC, Deutz NEP, Lee A. Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. J Hepatol. 2004;41(4):613–20.CrossRefPubMedGoogle Scholar
  20. 20.
    Olafsson S, Gottstein J, Blei AT. Brain edema and intracranial hypertension in rats after total hepatectomy. Gastroenterology. 1995;108(4):1097–103.CrossRefPubMedGoogle Scholar
  21. 21.
    Arkadopoulos N, Chen SC, Khalili TM, Detry O, Hewitt WR, Lilja H, et al. Transplantation of hepatocytes for prevention of intracranial hypertension in pigs with ischemic liver failure. Cell Transplant. 1998;7(4):357–63.CrossRefPubMedGoogle Scholar
  22. 22.
    Detry O, Arkadopoulos N, Ting P, Kahaku E, Margulies J, Arnaout W, et al. Intracranial pressure during liver transplantation for fulminant hepatic failure. Transplantation. 1999;67(5):767–70.CrossRefPubMedGoogle Scholar
  23. 23.
    Jalan R, Pollok A, Shah SH, Madhavan K, Simpson KJ. Liver derived pro-inflammatory cytokines may be important in producing intracranial hypertension in acute liver failure. J Hepatol. 2002;37(4):536–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Larsen FS, Ejlersen E, Hansen BA, Knudsen GM, Tygstrup N, Secher NH. Functional loss of cerebral blood flow autoregulation in patients with fulminant hepatic failure. J Hepatol. 1995;23(2):212–7.CrossRefPubMedGoogle Scholar
  25. 25.
    Blei AT. The pathophysiology of brain edema in acute liver failure. Neurochem Int. 2005;47(1–2):71–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Rama Rao KV, Jayakumar AR, Tong X, Alvarez VM, Norenberg MD. Marked potentiation of cell swelling by cytokines in ammonia-sensitized cultured astrocytes. J Neuroinflammation. 2010;7(1):1–8.CrossRefGoogle Scholar
  27. 27.
    Bémeur C, Qu H, Desjardins P, Butterworth RF. IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure. Neurochem Int. 2010; 56(2):213–5.CrossRefPubMedGoogle Scholar
  28. 28.
    Lee WM, Stravitz RT, Larson AM. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology. 2012;55(3):965–7.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Munoz SJ, Robinson M, Northrup B, Bell R, Moritz M, Jarrell B, et al. Elevated intracranial pressure and computed tomography of the brain in fulminant hepatocellular failure. Hepatology. 1991;13(2):209–12.CrossRefPubMedGoogle Scholar
  30. 30.
    Traber PG, Ganger DR, Blei AT. Brain edema in rabbits with galactosamine-induced fulminant hepatitis. Regional differences and effects on intracranial pressure. Gastroenterology. 1986;91(6):1347–56.CrossRefPubMedGoogle Scholar
  31. 31.
    Detry O, De Roover A, Honore P, Meurisse M. Brain edema and intracranial hypertension in fulminant hepatic failure: pathophysiology and management. World J Gastroenterol. 2006;12(46):7405–12.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Davies MH, Mutimer D, Lowes J, Elias E, Neuberger J. Recovery despite impaired cerebral perfusion in fulminant hepatic failure. Lancet. 1994;343(8909):1329–30.CrossRefPubMedGoogle Scholar
  33. 33.
    Chesnut RM, Temkin N, Carney N, Dikmen S, Rondina C, Videtta W, et al. A trial of intracranial-pressure monitoring in traumatic brain injury. N Engl J Med. 2012;367(26):2471–81.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Vaquero J, Fontana RJ, Larson AM, Bass NM, Davern TJ, Shakil AO, et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl. 2005;11(12):1581–9.CrossRefPubMedGoogle Scholar
  35. 35.
    Karvellas CJ, Fix OK, Battenhouse H, Durkalski V, Sanders C, Lee WM. Outcomes and complications of intracranial pressure monitoring in acute liver failure: a retrospective cohort study. Crit Care Med. 2014;42(5):1157–67.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Peck M, Wendon J, Sizer E, Auzinger G, Bernal W. Intracranial pressure monitoring in acute liver failure: a review of 10 years experience. Crit Care. 2010;14(1):1.CrossRefGoogle Scholar
  37. 37.
    Kamat P, Kunde S, Vos M, Vats A, Gupta N, Heffron T, et al. Invasive intracranial pressure monitoring is a useful adjunct in the management of severe hepatic encephalopathy associated with pediatric acute liver failure. Pediatr Crit Care Med. 2012;13(1):e33–8.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Sheinberg M, Kanter MJ, Robertson CS, Contant CF, Narayan RK, Grossman RG. Continuous monitoring of jugular venous oxygen saturation in head-injured patients. J Neurosurg. 1992;76(2):212–7.CrossRefPubMedGoogle Scholar
  39. 39.
    Sawhney R, Holland-Fischer P, Rosselli M, Mookerjee RP, Agarwal B, Jalan R. Role of ammonia, inflammation, and cerebral oxygenation in brain dysfunction of acute-on-chronic liver failure patients. Liver Transpl. 2016;22(6):732–42.CrossRefPubMedGoogle Scholar
  40. 40.
    Bellner J, Romner B, Reinstrup P, Kristiansson KA, Ryding E, Brandt L. Transcranial Doppler sonography pulsatility index (PI) reflects intracranial pressure (ICP). Surg Neurol. 2004;62(1):45–51.CrossRefPubMedGoogle Scholar
  41. 41.
    Kawakami M, Koda M, Murawaki Y. Cerebral pulsatility index by transcranial Doppler sonography predicts the prognosis of patients with fulminant hepatic failure. Clin Imaging. 2010;34(5):327–31.CrossRefPubMedGoogle Scholar
  42. 42.
    Abdo A, Perez-Bernal J, Hinojosa R, Porras F, Castellanos R, Gomez F, et al. Cerebral hemodynamics patterns by transcranial Doppler in patients with acute liver failure. Transplant Proc. 2015;47(9):2647–9.CrossRefPubMedGoogle Scholar
  43. 43.
    Aggarwal S, Brooks DM, Kang Y, Linden PK, Patzer JF. Noninvasive monitoring of cerebral perfusion pressure in patients with acute liver failure using transcranial doppler ultrasonography. Liver Transpl. 2008;14(7):1048–57.CrossRefPubMedGoogle Scholar
  44. 44.
    Nielsen HB, Tofteng F, Wang LP, Larsen FS. Cerebral oxygenation determined by near-infrared spectrophotometry in patients with fulminant hepatic failure. J Hepatol. 2003;38(2):188–92.CrossRefPubMedGoogle Scholar
  45. 45.
    Helmke K, Burdelski M, Hansen HC. Detection and monitoring of intracranial pressure dysregulation in liver failure by ultrasound. Transplantation. 2000;70(2):392–5.CrossRefPubMedGoogle Scholar
  46. 46.
    Krishnamoorthy V, Beckmann K, Mueller M, Sharma D, Vavilala MS. Perioperative estimation of the intracranial pressure using the optic nerve sheath diameter during liver transplantation. Liver Transpl. 2013;19(3):246–9.CrossRefPubMedGoogle Scholar
  47. 47.
    Bratton SL, Chestnut RM, Ghajar J, McConnell Hammond FF, Harris OA, Hartl R, et al. Guidelines for the management of severe traumatic brain injury. VIII. Intracranial pressure thresholds. J Neurotrauma. 2007;24(Suppl 1):S55–8.PubMedGoogle Scholar
  48. 48.
    Kredel M, Muellenbach RM, Brock RW, Wilckens HH, Brederlau J, Roewer N, et al. Liver dysfunction after lung recruitment manoeuvres during pressure-controlled ventilation in experimental acute respiratory distress. Crit Care. 2007;11(1):R13.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Ede RJ, Gimson AE, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol. 1986;2(1):43–51.CrossRefPubMedGoogle Scholar
  50. 50.
    Kodakat S, Gopal P, Wendon J. Hyperglycaemia is associated with intracranial hypertension in patients with acute liver failure. Liver Transpl. 2001;7:C-21.Google Scholar
  51. 51.
    Sonneville R, Vanhorebeek I, den Hertog HM, Chrétien F, Annane D, Sharshar T, et al. Critical illness-induced dysglycemia and the brain. Intensive Care Med. 2015;41(2):192–202.CrossRefPubMedGoogle Scholar
  52. 52.
    Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–97.CrossRefPubMedGoogle Scholar
  53. 53.
    Meier R, Bechir M, Ludwig S, Sommerfeld J, Keel M, Steiger P, et al. Differential temporal profile of lowered blood glucose levels (3.5 to 6.5 mmol/l versus 5 to 8 mmol/l) in patients with severe traumatic brain injury. Crit Care. 2008;12(4):R98.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016;40(2):159–211.CrossRefPubMedGoogle Scholar
  55. 55.
    Plauth M, Cabre E, Campillo B, Kondrup J, Marchesini G, Schutz T, et al. ESPEN guidelines on parenteral nutrition: hepatology. Clin Nutr. 2009;28(4):436–44.CrossRefPubMedGoogle Scholar
  56. 56.
    Antoniades CG, Berry PA, Wendon JA, Vergani D. The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol. 2008;49(5):845–61.CrossRefPubMedGoogle Scholar
  57. 57.
    Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Casewell M, et al. Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol. 1991;12(1):1–9.CrossRefPubMedGoogle Scholar
  58. 58.
    Karvellas CJ, Cavazos J, Battenhouse H, Durkalski V, Balko J, Sanders C, et al. Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: a retrospective cohort study. Clin Gastroenterol Hepatol. 2014;12(11):1942–9.e1.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Bhatia V, Batra Y, Acharya SK. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure—a controlled clinical trial. J Hepatol. 2004;41(1):89–96.CrossRefPubMedGoogle Scholar
  60. 60.
    Sharma BC, Sharma P, Lunia MK, Srivastava S, Goyal R, Sarin SK. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. Am J Gastroenterol. 2013;108(9):1458–63.CrossRefPubMedGoogle Scholar
  61. 61.
    Rees CJ, Oppong K, Al Mardini H, Hudson M, Record CO. Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial. Gut. 2000;47(4):571–4.CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Acharya SK, Bhatia V, Sreenivas V, Khanal S, Panda SK. Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology. 2009;136(7):2159–68.CrossRefPubMedGoogle Scholar
  63. 63.
    Slack AJ, Auzinger G, Willars C, Dew T, Musto R, Corsilli D, et al. Ammonia clearance with haemofiltration in adults with liver disease. Liver Int. 2014;34(1):42–8.CrossRefPubMedGoogle Scholar
  64. 64.
    Novelli G, Rossi M, Pretagostini M, Pugliese F, Ruberto F, Novelli L, et al. One hundred sixteen cases of acute liver failure treated with MARS. Transplant Proc. 2005;37(6):2557–9.CrossRefPubMedGoogle Scholar
  65. 65.
    Saliba F, Camus C, Durand F, Mathurin P, Letierce A, Delafosse B, et al. Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial. Ann Intern Med. 2013;159(8):522–31.CrossRefPubMedGoogle Scholar
  66. 66.
    Demetriou AA, Brown RS Jr, Busuttil RW, Fair J, McGuire BM, Rosenthal P, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg. 2004;239(5):660–7.CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Clemmesen JO, Kondrup J, Nielsen LB, Larsen FS, Ott P. Effects of high-volume plasmapheresis on ammonia, urea, and amino acids in patients with acute liver failure. Am J Gastroenterol. 2001;96(4):1217–23.CrossRefPubMedGoogle Scholar
  68. 68.
    Larsen FS, Schmidt LE, Bernsmeier C, Rasmussen A, Isoniemi H, Patel VC, et al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol. 2016;64(1):69–78.CrossRefPubMedGoogle Scholar
  69. 69.
    Marshall LF, Smith RW, Rauscher LA, Shapiro HM. Mannitol dose requirements in brain-injured patients. J Neurosurg. 1978;48(2):169–72.CrossRefPubMedGoogle Scholar
  70. 70.
    Kamel H, Navi BB, Nakagawa K, Hemphill JC 3rd, Ko NU. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med. 2011;39(3):554–9.CrossRefPubMedGoogle Scholar
  71. 71.
    Li M, Chen T, Chen S-d, Cai J, Hu Y-h. Comparison of equimolar doses of mannitol and hypertonic saline for the treatment of elevated intracranial pressure after traumatic brain injury: a systematic review and meta-analysis. Medicine. 2015;94(17):e736.PubMedGoogle Scholar
  72. 72.
    Robertson CS, Valadka AB, Hannay HJ, Contant CF, Gopinath SP, Cormio M, et al. Prevention of secondary ischemic insults after severe head injury. Crit Care Med. 1999;27(10):2086–95.CrossRefPubMedGoogle Scholar
  73. 73.
    Lang EW, Czosnyka M, Mehdorn HM. Tissue oxygen reactivity and cerebral autoregulation after severe traumatic brain injury. Crit Care Med. 2003;31(1):267–71.CrossRefPubMedGoogle Scholar
  74. 74.
    Shalimar Acharya SK. Management in acute liver failure. J Clin Exp Hepatol. 2015;5(Suppl 1):S104–15.CrossRefPubMedGoogle Scholar
  75. 75.
    Balestreri M, Czosnyka M, Hutchinson P, Steiner LA, Hiler M, Smielewski P, et al. Impact of intracranial pressure and cerebral perfusion pressure on severe disability and mortality after head injury. Neurocrit Care. 2006;4(1):8–13.CrossRefPubMedGoogle Scholar
  76. 76.
    Eefsen M, Dethloff T, Frederiksen H-J, Hauerberg J, Hansen BA, Larsen FS. Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic support. J Hepatol. 2007;47(3):381–6.CrossRefPubMedGoogle Scholar
  77. 77.
    Clemmesen JO, Hansen BA, Larsen FS. Indomethacin normalizes intracranial pressure in acute liver failure: a twenty-three-year-old woman treated with indomethacin. Hepatology. 1997;26(6):1423–5.CrossRefPubMedGoogle Scholar
  78. 78.
    Tofteng F, Larsen FS. The effect of indomethacin on intracranial pressure, cerebral perfusion and extracellular lactate and glutamate concentrations in patients with fulminant hepatic failure. J Cereb Blood Flow Metab. 2004;24(7):798–804.CrossRefPubMedGoogle Scholar
  79. 79.
    Vaquero J. Therapeutic hypothermia in the management of acute liver failure. Neurochem Int. 2012;60(7):723–35.CrossRefPubMedGoogle Scholar
  80. 80.
    Jalan R, Olde Damink SW, Deutz NE, Hayes PC, Lee A. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology. 2004;127(5):1338–46.CrossRefPubMedGoogle Scholar
  81. 81.
    Karvellas CJ, Todd Stravitz R, Battenhouse H, Lee WM, Schilsky ML, USALFSG. Therapeutic hypothermia in acute liver failure: a multicenter retrospective cohort analysis. Liver Transpl. 2015;21(1):4–12.CrossRefPubMedPubMedCentralGoogle Scholar
  82. 82.
    Bernal W, Murphy N, Brown S, Whitehouse T, Bjerring PN, Hauerberg J, et al. A multicentre randomized controlled trial of moderate hypothermia to prevent intracranial hypertension in acute liver failure. J Hepatol. 2016;65:273–9.CrossRefPubMedGoogle Scholar
  83. 83.
    Andrews PJ, Sinclair HL, Rodriguez A, Harris BA, Battison CG, Rhodes JK, et al. Hypothermia for intracranial hypertension after traumatic brain injury. N Engl J Med. 2015;373(25):2403–12.CrossRefPubMedGoogle Scholar
  84. 84.
    Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, et al. Targeted temperature management at 33 degrees C versus 36 degrees C after cardiac arrest. N Engl J Med. 2013;369(23):2197–206.CrossRefPubMedGoogle Scholar
  85. 85.
    Rozga J, Podesta L, LePage E, Hoffman A, Morsiani E, Sher L, et al. Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet. 1993;342(8876):898–9.CrossRefPubMedGoogle Scholar
  86. 86.
    Sanabria Mateos R, Hogan NM, Dorcaratto D, Heneghan H, Udupa V, Maguire D, et al. Total hepatectomy and liver transplantation as a two-stage procedure for fulminant hepatic failure: a safe procedure in exceptional circumstances. World J Hepatol. 2016;8(4):226–30.CrossRefPubMedPubMedCentralGoogle Scholar
  87. 87.
    Bismuth H, Samuel D, Castaing D, Adam R, Saliba F, Johann M, et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg. 1995;222(2):109–19.CrossRefPubMedPubMedCentralGoogle Scholar
  88. 88.
    Keays R, Potter D, O’Grady J, Peachey T, Alexander G, Williams R. Intracranial and cerebral perfusion pressure changes before, during and immediately after orthotopic liver transplantation for fulminant hepatic failure. Q J Med. 1991;79(289):425–33.PubMedGoogle Scholar
  89. 89.
    Lidofsky SD, Bass NM, Prager MC, Washington DE, Read AE, Wright TL, et al. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology. 1992;16(1):1–7.CrossRefPubMedGoogle Scholar
  90. 90.
    Prager MC, Washington DE, Lidofsky SD, Kelley SD, White JD. Intracranial pressure monitoring during liver transplant without venovenous bypass for fulminant hepatic failure. Transplant Proc. 1993;25(2):1841.PubMedGoogle Scholar
  91. 91.
    Sakai T, Planinsic RM, Hilmi IA, Marsh JW. Complications associated with percutaneous placement of venous return cannula for venovenous bypass in adult orthotopic liver transplantation. Liver Transpl. 2007;13(7):961–5.CrossRefPubMedGoogle Scholar
  92. 92.
    Gurusamy KS, Koti R, Pamecha V, Davidson BR. Veno-venous bypass versus none for liver transplantation. Cochrane Database Syst Rev. 2011;(3):Cd007712.Google Scholar
  93. 93.
    Joshi D, O’Grady J, Patel A, Shawcross D, Connor S, Deasy N, et al. Cerebral oedema is rare in acute-on-chronic liver failure patients presenting with high-grade hepatic encephalopathy. Liver Int. 2014;34(3):362–6.CrossRefPubMedGoogle Scholar
  94. 94.
    Jepsen P, Ott P, Andersen PK, Sorensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology. 2010;51(5):1675–82.CrossRefPubMedGoogle Scholar
  95. 95.
    Shawcross DL, Sharifi Y, Canavan JB, Yeoman AD, Abeles RD, Taylor NJ, et al. Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. J Hepatol. 2011;54(4):640–9.CrossRefPubMedGoogle Scholar
  96. 96.
    Dawwas MF, Lewsey JD, Neuberger JM, Gimson AE. The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study. Liver Transpl. 2007;13(8):1115–24.CrossRefPubMedGoogle Scholar
  97. 97.
    Gines P, Guevara M. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology. 2008;48(3):1002–10.CrossRefPubMedGoogle Scholar
  98. 98.
    Hudcova J, Ruthazer R, Bonney I, Schumann R. Sodium homeostasis during liver transplantation and correlation with outcomes. Anesth Analg. 2014;119(6):1420–8.CrossRefPubMedGoogle Scholar
  99. 99.
    Yan L, Xie F, Lu J, Ni Q, Shi C, Tang C, et al. The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials. BMC Gastroenterol. 2015;15:65.CrossRefPubMedPubMedCentralGoogle Scholar
  100. 100.
    Lizaola B, Bonder A, Tapper EB, Mendez-Bocanegra A, Cardenas A. The changing role of sodium management in cirrhosis. Curr Treat Options Gastroenterol. 2016;14(2):274–84.CrossRefPubMedGoogle Scholar
  101. 101.
    Živković SA. Neurologic complications after liver transplantation. World J Hepatol. 2013;5(8):409–16.CrossRefPubMedPubMedCentralGoogle Scholar
  102. 102.
    Saner FH, Nadalin S, Radtke A, Sotiropoulos GC, Kaiser GM, Paul A. Liver transplantation and neurological side effects. Metab Brain Dis. 2009;24(1):183–7.CrossRefPubMedGoogle Scholar
  103. 103.
    Chan G, Taqi A, Marotta P, Levstik M, McAlister V, Wall W, et al. Long-term outcomes of emergency liver transplantation for acute liver failure. Liver Transpl. 2009;15(12):1696–702.CrossRefPubMedGoogle Scholar
  104. 104.
    Vizzini G, Asaro M, Miraglia R, Gruttadauria S, Fili D, D’Antoni A, et al. Changing picture of central nervous system complications in liver transplant recipients. Liver Transpl. 2011;17(11):1279–85.CrossRefPubMedGoogle Scholar
  105. 105.
    Guarino M, Benito-Leon J, Decruyenaere J, Schmutzhard E, Weissenborn K, Stracciari A. Neurological problems in liver transplantation. In: Gilhus NE, Barnes MR, Brainin M, editors. European handbook of neurological management. 2nd ed. Oxford: Wiley-Blackwell; 2011. p. 491–9.Google Scholar
  106. 106.
    KA F, DiNorcia J, Sher L, Velani SA, Akhtar S, Kalayjian LA, et al. Predictive factors of neurological complications and one-month mortality after liver transplantation. Front Neurol. 2014;5:275.Google Scholar
  107. 107.
    Rovira A, Alonso J, Cordoba J. MR imaging findings in hepatic encephalopathy. Am J Neuroradiol. 2008;29(9):1612–21.CrossRefPubMedGoogle Scholar
  108. 108.
    Garcia-Martinez R, Rovira A, Alonso J, Jacas C, Simon-Talero M, Chavarria L, et al. Hepatic encephalopathy is associated with posttransplant cognitive function and brain volume. Liver Transpl. 2011;17(1):38–46.CrossRefPubMedGoogle Scholar
  109. 109.
    Kok B, Foxton MR, Clough C, Shawcross DL. Rifaximin is an efficacious treatment for the Parkinsonian phenotype of hepatic encephalopathy. Hepatology. 2013;58(4):1516–7.CrossRefPubMedGoogle Scholar
  110. 110.
    Qavi AH, Hammad S, Rana AI, Salih M, Shah NH, Dar FS, et al. Reversal of acquired hepatocerebral degeneration with living donor liver transplantation. Liver Transpl. 2016;22(1):125–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Prashanth Nandhabalan
    • 1
  • Chris Willars
    • 1
  • Georg Auzinger
    • 1
  1. 1.Department of Critical Care/Institute of Liver StudiesKing’s College HospitalLondonUK

Personalised recommendations